Diagnostics Archives

first page of Role Of In Vitro Diagnostic Testing Backgrounder

COVID-19 / Diagnostics

COVID-19: The Role Of In Vitro Diagnostic Testing – Backgrounder

Read background information on how AdvaMedDx®’s members produce IVD tests to detect COVID-19.

Diagnostics

AdvaMed®’s National Testing Registry: Shipments of COVID-19 Molecular Diagnostic Tests Reach 100 Million

WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) today announced that total U.S. shipments of COVID-19 molecular diagnostic tests reached approximately 100 million, as of July 25, based on the latest…

medical worker administers covid test to patient

COVID-19 / Diagnostics

Op-Ed: AdvaMed®’s Whitaker Details New National Testing Supply Registry

Unequal access to medical technologies and, more broadly, health care services continues to persist – often disproportionately impacting the lives of racial and ethnic minorities.

COVID-19 / Diagnostics

COVID Test Shipments Top One Million Per Day

AdvaMed® announced that shipments of COVID-19 molecular diagnostic tests reached one million per day for the week ending July 24, based on the latest data from the association’s National Testing Registry.

Diagnostics

AdvaMed® Unveils National Testing Registry to Aid in Fight Against COVID-19, Releases First Data Set

Whitaker Calls National Registry “Crucial Tool” for Federal, State Authorities; Announces More Than 65 Million Tests Shipped Nationwide Since Beginning of Pandemic WASHINGTON, D.C. – In its latest action to help ensure…

Diagnostics

AdvaMedDx® Statement On Serology/Antibody Testing

WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) today released the following statement from Susan Van Meter, executive director of AdvaMedDx®, in response to comments on COVID-19 serology/antibody testing at today’s hearing…